← SynDRA
PONALRESTAT
SynDRA canonical compound SYN0000150 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | AKR1B1 |
| Mechanism of action | Aldose reductase inhibitor |
All known targets
Mechanisms of action (all sources)
- Aldose reductase inhibitor
- SLC5A4 BLOCKER
- AKR1B1 INHIBITOR
Drug classes
- Enzyme Inhibitors
- Hypoglycemic Agents
Cross-references
Synonyms
- ICI 128,436
- ICI-128436
- statil
- Ponalrestatum [Latin]
- UNII-2CV0A5G64E
- CHEMBL7679
- C17H12BrFN2O3
- 2CV0A5G64E
- 2-(3-(4-bromo-2-fluorobenzyl)-4-oxo-3,4-dihydrophthalazin-1-yl)acetic acid
- NCGC00024824-01
- 3-(4-Bromo-2-fluorobenzyl)-3,4-dihydro-4-oxo-1-phthalazineacetic acid
- 1-Phthalazineaceticacid, 3-[(4-bromo-2-fluorophenyl)methyl]-3,4-dihydro-4-oxo-
- Ponalrestatum
- 1-Phthalazineacetic acid, 3-((4-bromo-2-fluorophenyl)methyl)-3,4-dihydro-4-oxo-
- Prodiax
- Ponalrestat [USAN:BAN:INN]
- ISIS-5GLT2rx
- DTXCID9025665
- RefChem:929869
- MFCD00204117
- Ponalrestat [USAN:INN:BAN]
- LKBFFDOJUKLQNY-UHFFFAOYSA-N
- MK-538
- Ponalrestat (statil)
- MK-538;Statil
- Spectrum_001483
- STATIL?
- Tocris-0847
- SpecPlus_000843
- Spectrum2_001467
- Spectrum3_001048
- Spectrum4_001188
- PONALRESTAT [INN]
- Ponalrestat (USAN/INN)
- PONALRESTAT [USAN]
- PONALRESTAT [MART.]
- SCHEMBL49154
- BSPBio_002576
Look up PONALRESTAT in the interactive SynDRA portal →